Searched for
AKUMS DRUGS GMP
Trump’s tariffs shake global pharma—India at the crossroads of crisis and opportunityWith Trump’s tariffs poised to disrupt global pharma trade, industry stakeholders see opportunities for India, provided it takes strategic ...
Akum Drugs shares tumble 5% despite posting Rs 60 crore Q1 profitAkum Drugs Share Price: Akum Drugs and Pharmaceuticals' shares dropped 5% to Rs 895 despite reporting a Rs 60 crore net profit for the June...
Ceigall India IPO share allotment soon: Check status, GMP, listing date and other detailsThe Ceigall India IPO share allotment was determined, with shares given out through a lottery system overseen by Link Intime India. Investo...
Akums Drugs and Pharma shares jump 8% post listing. Should you buy, sell or hold?Akums Drugs and Pharmaceuticals saw its shares rise 8% to Rs 784.6 on its debut, despite a strong subscription rate of 63.44 times. Analyst...
Akums Drugs and Pharma shares list at 7% premium over issue priceAkums Drugs and Pharmaceuticals' shares began trading at Rs 725, a 6.8% premium over the issue price of Rs 679, after an IPO that was subsc...
Ceigall India IPO subscribed 13.78 times on last day of bidding process. Check GMP and other detailsHighest demand was driven by qualified institutional buyers as the portion was booked 31.5 times, followed by the non-institutional investo...
Ola Electric IPO sails through on Day 2. Check GMPThe initial public offering of Ola Electric was fully subscribed on the second day. Retail investors' portion was oversubscribed 2.87 times...
Akums Drugs and Pharma shares to list on Tuesday. Here's what GMP suggestsAkums Drugs and Pharmaceuticals will debut on Tuesday. The stock, with a GMP of Rs 140, is expected to list at a 21% premium over the upper...
Akums Drugs & Pharma IPO share allotment to be finalised today: Check status, GMP, listing date and other detailsAkums Drugs & Pharma share allotment has been finalised. Shares will be out on August 6. The IPO was subscribed 63.5 times. Proceeds will a...
Akums Drugs and Pharma IPO: Check subscription on Day 3, GMP and other detailsNon-institutional investors subscribed 22.8 times, followed by retail investors, whose category was booked 13.8 times. The part reserved fo...
Akums Drugs and Pharma IPO: Check subscription on Day 2, GMP and other detailsIn the unlisted market, shares of the company are currently commanding a premium of 26% over the IPO price, with GMP of Rs 175. The IPO its...
Akums Drugs and Pharma IPO opens for subscription. Should you bid?Akums Drugs IPO Review GMP, Subs: Akums Drugs and Pharmaceuticals' IPO, valued at Rs 1,857 crore, closed on August 1. The issue included Rs...
Akums Drugs and Pharma IPO opens tomorrow: Price band, GMP among 10 things to know before subscribingAkums Drugs and Pharma's IPO, open from July 30 to August 1, targets raising Rs 1857 crore. The company specializes in pharmaceutical devel...
Akums Drugs and Pharmaceuticals Rs 1,857 crore IPO opens Tuesday. Check price band, other detailsAkums Drugs and Pharmaceuticals' Rs 1,857 crore IPO opened from July 30 to August 1, featuring a Rs 680 crore fresh issue and 1.73 crore sh...
Decoded: How India makes affordable drugs for developed world, but ‘deadly’ medicines for developing countriesIndia is called the 'pharmacy of the world' because it makes and exports drugs worth millions of dollars to many countries. But recent inci...
Tarnished by cough syrup deaths, India’s pharma industry tries to look beyond the stuporThe reputation of the Indian pharma sector has seen some setbacks lately but the industry is strong enough to make a comeback.
Akums enters into a pact with Leiutis, Biophore for bringing therapeutics to IndiaThis association is set to bring succour in therapy areas of CNS disorders, pain management, and hormonal disorders, where there is a gap i...